“Our conviction on Divis is more from a stock-specific perspective rather than from a category oriented perspective. Divis is a firm where half of its business is not API related. It is a contract manufacturing of patented molecules largely etc. And as a result of this part of the business, there tends to be a lot of volatility from quarter to quarter in reported results.”